Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Sildenafil vs Viagra in Healthy Thai Males
NCT06289881Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Bio-innova. Primary endpoints: Area under the plasma concentration-time curve from time zero to the last measurable concentration at 24 hours, Maximal measured plasma concentration at 24 hours and 1 more. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
sildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06289881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289881.